Mr Mark Larragoite, RPH in Albuquerque, NM - Pharmacist

Mr Mark Larragoite, RPH is a Pharmacist based in Albuquerque, New Mexico. Mr Mark Larragoite is licensed to practice in New Mexico (license number RP00004609) and his current practice location is 2801 Eubank Blvd Ne Ste A, Albuquerque, New Mexico. He can be reached at his office (for appointments etc.) via phone at (505) 294-1597.

NPI number for Mr Mark Larragoite is 1043436595 and his current mailing address is 9409 Oakmont Rd Ne, Albuquerque, New Mexico. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1043436595.

Contact Information

	Mr Mark Larragoite, RPH
	2801 Eubank Blvd Ne Ste A, Albuquerque, NM 87112-1300
	(505) 294-1597
	(505) 275-0340

Healthcare Provider's Profile

Full Name	Mr Mark Larragoite
Gender	Male
Speciality	Pharmacist
Location	2801 Eubank Blvd Ne Ste A, Albuquerque, New Mexico
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1043436595
Provider Enumeration Date: 04/17/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Mr Mark Larragoite such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043436595	NPI	-	NPPES
RP00004609	Other	NM	RPH LICENSE-PROVIDER ID

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	RP00004609 (New Mexico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Mark Larragoite is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Mark Larragoite, RPH 9409 Oakmont Rd Ne, Albuquerque, NM 87111-5822 Ph: (505) 857-9252	Mr Mark Larragoite, RPH 2801 Eubank Blvd Ne Ste A, Albuquerque, NM 87112-1300 Ph: (505) 294-1597

News Archive

Abraxis BioScience to present updated survival findings from ABRAXANE Phase I/II trial at 101st AACR meeting

Abraxis BioScience, Inc., a fully integrated biotechnology company, announced that the updated survival findings from a Phase I/II clinical trial evaluating the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for first-line treatment of patients with metastatic pancreatic cancer will be discussed during a keynote address on April 20 at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held in Washington, D.C.

Arrayit selects PMA pathway for OvaDx Pre-Symptomatic Ovarian Cancer Screening Test

Arrayit Corporation, a leader in life sciences and healthcare technology, announces today that the company has chosen the Premarket Approval pathway for its OvaDx Pre-Symptomatic Ovarian Cancer Screening Test. While the standard for a PMA is higher than for a 510(k), the company believes that a PMA OvaDx submission can achieve a Class III PMA approval, the most stringent approval level granted by the FDA for in vitro diagnostic devices.

Smart for Life Cookie Diet selected to receive 2010-2011 Shining Star Award

The trailblazing company whose Smart for Life weight management products featuring the Smart for Life Cookie Diet component was recently selected to receive the Unicorn Children's Foundation 2010-2011 Shining Star Award. This award recognizes an individual or organization that has brought significant awareness to the issues associated with developmental, communication, and learning disorders.

Data from Concert Pharmaceuticals' CTP-499 study to be presented at ASN Kidney Week 2011

Concert Pharmaceuticals, Inc. today announced that three abstracts relating to CTP-499, its clinical candidate for the potential treatment of diabetic nephropathy, have been accepted for poster presentations at the American Society of Nephrology's (ASN) Kidney Week 2011.

New York Times reports on controversy surrounding Syrian aid; WFP to feed 2.5M people in Syria by April

The New York Times examines the controversy surrounding humanitarian aid to Syria, writing, "The United States and other international donors are spending hundreds of millions of dollars on humanitarian aid for Syrians afflicted by the civil war. But here in the rebel-controlled north, where the deprivation is most acute, that money has bought mostly anger and resentment: the vast majority of aid is going to territory controlled by President Bashar al-Assad, and the small amount reaching opposition-held areas is all but invisible."

Pharmacist in Albuquerque, NM

Dr. Rochelle Fliethman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4710 Jefferson St Ne, Albuquerque, NM 87109 Phone: 505-955-9454 Fax: 505-888-9644
Mr. David Lewis Gottheimer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2625 San Pedro Drive, Albuquerque, NM 87110 Phone: 505-237-9027
Roxanna Love Vick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11825 Lomas Blvd Ne, Albuquerque, NM 87112 Phone: 505-293-9156 Fax: 505-323-1740
Ms. Maria Magdalena Lopez-villa, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5400 Gibson Blvd Se, Albuquerque, NM 87108 Phone: 505-727-5915 Fax: 505-727-1241
Mr. Michael Richardson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4209 San Pedro Dr Ne, 274, Albuquerque, NM 87109 Phone: 505-884-1584
Amanda P Sampson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1501 San Pedro Dr Se, Albuquerque, NM 87108 Phone: 505-265-1711
Dr. Kendra Saxvik, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1501 San Pedro Dr Se, Albuquerque, NM 87108 Phone: 505-265-1711

Mr Mark Larragoite, RPH - Pharmacist in Albuquerque, NM